|
|
40
|
A1032
|
APO-LABETALOL 200MG TAB (APO/COL)
|
100'S
|
A
|
0.71
|
200MG
|
120
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
42
|
A1032
|
APO-LABETALOL 200MG TAB (APO)
|
100'S
|
A
|
0.72
|
200MG
|
120
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
41
|
A103B
|
APO-LABETALOL 200MG TAB (APO)
|
100'S
|
A
|
0.7209
|
200MG
|
120
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
A151A
|
ADENOSINE 3MG/ML INJ (KWA/ATB)
|
10X2ML
|
BQ
|
4.76
|
3MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
A151F
|
ADENOSINE 3MG/ML INJ (LDP) (BQ)
|
10X2ML
|
BQ
|
5.1376
|
3MG/ML
|
30
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
A151H
|
ADENOSINE 3MG/ML INJ (MON/PHA)
|
10X2ML
|
BQ
|
5.21
|
3MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
42
|
A151H
|
ADENOSINE 3MG/ML INJ (MON)
|
10X2ML
|
BQ
|
1.78
|
3MG/ML
|
30
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
42
|
A151N
|
CARDIUREX 3MG/ML INJ (JLP) ADENOSINE
|
30X2ML
|
BQ
|
1.92
|
3MG/ML
|
30
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
A1813
|
ELECTROLYTES SOLN (BAX/STO)
|
1 LITRE
|
BQ
|
13.86
|
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
A1813
|
ELECTROLYTES SOLN (BAX)
|
1 LITRE
|
BQ
|
16.2556
|
|
50
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
A1813
|
ELECTROLYTES SOLN (BAX)
|
1 LITRE
|
BQ
|
5.06
|
|
50
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
A1916
|
ALPROSTADIL 500MCG/ML INJ (SLS/AHI)
|
1ML AMP
|
BQ
|
399.59
|
500MCG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
42
|
A1916
|
ALPROSTADIL 500MCG/ML INJ (SLS)
|
1ML AMP
|
BQ
|
398.07
|
500MCG/ML
|
7
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
A1917
|
BIOGLANDIN 500MCG/ML INJ (UBI/RXP) ALPROSTADI
|
1ML AMP
|
BQ
|
237.85
|
500MCG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
A1919
|
ALPROSTADIL 500MCG/ML INJ (KWA)
|
1ML AMP
|
BQ
|
485.2208
|
500MCG/ML
|
7
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
A2313
|
NEURONTIN 300MG CAP (PFI/STO) GABAPENTIN
|
100'S
|
C
|
1.50
|
300MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
A2313
|
NEURONTIN 300MG CAP (PFI) GABAPENTIN (C)
|
100'S
|
C
|
1.5144
|
300MG
|
180
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
A2314
|
APO-GABAPENTIN 300MG CAP (APO/COL)
|
100'S
|
A
|
0.12
|
300MG
|
180
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
42
|
A2314
|
APO-GABAPENTIN 300MG CAP (APO)
|
100'S
|
C
|
0.13
|
300MG
|
180
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
A231AE
|
GABAPENTIN 300MG CAP (FSB)
|
100'S
|
A
|
0.07
|
300MG
|
180
|
2026-04-01
|
|
No
|
No
|
Add to Contract as Cat A
|
6
|